All episodes
SCOUT· 20%10m·2026-03-31·News Politics
SCOUT· 20%10m·2026-03-31·News PoliticsIndia commoditised Novo's blockbuster obesity drug. Novo's not flinching
Daybreak · 717
Semaglutide's patent just expired in India. The molecule behind Novo Nordisk's blockbuster obesity drugs, Ozempic and Wegovy, is now fair game for generic manufacturers. An 85 to 90% price drop is expected. Eli Lilly's Mounjaro had already been outselling Wegovy. For most companies, this would be the beginning of an…
Buzzmeter · cross-platform
20%
SCOUT
Scout bees are checking it out — divided opinions, the swarm hasn't committed.
Hive Vote · Skep listeners
New on SkepAwaiting the hive's first votes
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
Recent reviews
- No reviews yet — be the first.
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.